Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature

Y Xu, J Qiao - Journal of healthcare engineering, 2022 - Wiley Online Library
The polycystic ovary syndrome (PCOS) is the disease featured by elevated levels of
androgens, ovulatory dysfunction, and morphological abnormalities. At reproductive stage of …

Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment

HF Escobar-Morreale - Nature Reviews Endocrinology, 2018 - nature.com
Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic
disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a …

Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome

HJ Teede, CT Tay, JJE Laven, A Dokras… - European journal of …, 2023 - academic.oup.com
Study question What is the recommended assessment and management of those with
polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise …

Using human genetics to understand the disease impacts of testosterone in men and women

KS Ruth, FR Day, J Tyrrell, DJ Thompson, AR Wood… - Nature medicine, 2020 - nature.com
Testosterone supplementation is commonly used for its effects on sexual function, bone
health and body composition, yet its effects on disease outcomes are unknown. To better …

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome

HJ Teede, ML Misso, MF Costello, A Dokras… - Human …, 2018 - academic.oup.com
STUDY QUESTION What is the recommended assessment and management of women with
polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise …

Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update

S Abraham Gnanadass, Y Divakar Prabhu… - Archives of Gynecology …, 2021 - Springer
Background Polycystic ovarian syndrome (PCOS) is the most prevalent metabolic disorder
in reproductive-age women. It is indeed a multifactorial condition evidenced by ovarian …

Polycystic ovary syndrome

R Azziz, E Carmina, ZJ Chen, A Dunaif… - Nature reviews Disease …, 2016 - nature.com
Polycystic ovary syndrome (PCOS) affects 5–20% of women of reproductive age worldwide.
The condition is characterized by hyperandrogenism, ovulatory dysfunction and polycystic …

The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance

AH Balen, LC Morley, M Misso, S Franks… - Human reproduction …, 2016 - academic.oup.com
BACKGROUND Here we describe the consensus guideline methodology, summarise the
evidence-based recommendations we provided to the World Health Organisation (WHO) for …

Polycystic ovary syndrome

CR McCartney, JC Marshall - New England Journal of Medicine, 2016 - Mass Medical Soc
Key Clinical Points Polycystic Ovary Syndrome The polycystic ovary syndrome is diagnosed
in women with at least two of the following otherwise unexplained abnormalities …

Polycystic ovary syndrome: a disorder of reproductive age, its pathogenesis, and a discussion on the emerging role of herbal remedies

LH Zeng, S Rana, L Hussain, M Asif… - Frontiers in …, 2022 - frontiersin.org
Polycystic ovary syndrome (PCOS) is a very common, complex, and heterogeneous
endocrine disorder of women that involves a combination of environmental and genetic …